FDA Approves Linxibat: New Treatment for Cholestatic Itch in Adults
Berlin, Germany – March 19, 2026 – In a significant advancement for patients battling the debilitating itch associated with primary biliary cholangitis (PBC), the U.S. Food and Drug Administration (FDA) has approved linerixibat for the treatment of cholestatic pruritus in adults. The approval, announced today by Alfasigma, marks the first targeted therapy specifically developed to … Read more